This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignees: ETH Zurich, Harvard College, Massachusetts Institute of Technology. Active years: 2016-2021.
Company Filing History:
3 out of 554 
1 out of 3,071 
1 out of 8,576 
Years Active: 2016-2021
Title: The Innovative Contributions of Yaakov Benenson
Introduction
Yaakov Benenson is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for drug discovery and cellular biosensing. With a total of 4 patents to his name, Benenson's work has the potential to impact various aspects of medical research and treatment.
Latest Patents
One of Benenson's latest patents is a "Screening assay for identifying miRNA-specific drug compounds." This invention relates to a method for identifying microRNA (miRNA)-modulating compounds by utilizing a cell that contains a 'miRNA-specific module' and a 'non-specific RNAi module.' This method significantly reduces false positive results in miRNA screening assays, enhancing the reliability of drug discovery processes.
Another notable patent is the "Low-leakage cellular biosensor system." This invention comprises a cellular biosensor system that includes a repressor module and an output module. The system is designed to generate output signals in response to specific genetic interactions, making it useful for diagnosing diseases, drug discovery, and biomanufacturing methods.
Career Highlights
Throughout his career, Benenson has worked with prestigious institutions such as ETH Zurich and Harvard College. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Benenson has collaborated with notable individuals, including Ron Weiss and Liliana Wroblewska. These partnerships have further enriched his research and innovation efforts, leading to advancements in biotechnology.
Conclusion
Yaakov Benenson's innovative work in biotechnology, particularly in drug discovery and biosensing, showcases his significant contributions to the field. His patents reflect a commitment to advancing medical research and improving therapeutic strategies.